Precise Warfarin Management through Personalized Modeling and Control with Limited Clinical Data

2021 43RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE & BIOLOGY SOCIETY (EMBC)(2021)

引用 3|浏览3
暂无评分
摘要
Warfarin belongs to a medication class called anticoagulants or blood thinners. It is used for the treatment to prevent blood clots from forming or growing larger. Patients with venous thrombosis, pulmonary embolism, or who have suffered a heart attack, have an irregular heartbeat, or prosthetic heart valves are prescribed with warfarin. It is challenging to find optimal doses due to inter-patient and intra-patient variabilities and narrow therapeutic index. This work presents an individualized warfarin dosing method by utilizing the individual patient model generated using limited clinical data of the patients with chronic conditions under warfarin anticoagulation treatment. Then, the individual precise warfarin dosing is formalized as an optimal control problem, which is solved using the DORBF control approach. The efficiency of the proposed approach is compared with results obtained from practiced clinical protocol. Clinical Relevance- This establishes a framework for achieving personalized precise warfarin dosing strategies by utilizing personalized models and modern control techniques from limited clinical data.
更多
查看译文
关键词
Anticoagulants,Humans,Pulmonary Embolism,Thrombosis,Venous Thrombosis,Warfarin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要